PDS Biotechnology is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines. The Company plans to ...
PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results EMV Capital plc (AIM: EMVC), the deeptech and life sciences VC investment group, reports that its ...
PRINCETON, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune ...
PRINCETON, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback